APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ovulation Induction

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ovulation Induction Industry Growth and Trends Forecast to 2032

Report ID 174021310129 December 2025123 pages

Choose your research edition.

Industry ResearchOvulation Induction Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Ovulation Induction Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Ovulation Induction Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ovulation Induction Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Ovulation Induction Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

According to APO Research, the global Ovulation Induction market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ovulation Induction is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ovulation Induction is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ovulation Induction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Ovulation Induction market include Takeda, Sanofi, Merck & Co. Inc, AbbVie, AstraZeneca, Unichem Laboratories, Teva Pharmaceuticals USA, Inc, TerSera Therapeutics and Techwell, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ovulation Induction market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ovulation Induction market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ovulation Induction market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ovulation Induction.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Ovulation Induction market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ovulation Induction Market by Company

Takeda

Sanofi

Merck & Co. Inc

AbbVie

AstraZeneca

Unichem Laboratories

Teva Pharmaceuticals USA, Inc

TerSera Therapeutics

Techwell

Sun Pharmaceutical

Pharmascience Inc

Par pharmaceutical inc

Pacific Pharmaceuticals

LIVZON

Ipsen

IBSA

IBM Micromedex

Gedeon Richter

Fresenius Kabi

Ferring

Endo

EMD Serono Inc

Emcure Pharmaceuticals Ltd.

Cosette Pharmaceuticals, Inc

Bristol Myers Squibb

Ovulation Induction Segment by Type

Follicle Stimulating Hormone

Clomiphene Citrate

Human Menopausal Gonadotropin

Human Chorionic Gonadotropin

Others

Ovulation Induction Segment by Application

Clinic

Hospital

Medical Institution

Ovulation Induction Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ovulation Induction market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ovulation Induction and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ovulation Induction.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Ovulation Induction companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Ovulation Induction Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Ovulation Induction Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Ovulation Induction Market Share by Region (2021-2026) Table 4. Global Ovulation Induction Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Ovulation Induction Market Share by Region (2027-2032) Table 6. Global Ovulation Induction Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Ovulation Induction Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Ovulation Induction Market Size Share by Type (2021-2026) Table 9. Global Ovulation Induction Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Ovulation Induction Market Size Share Forecasted by Type (2027-2032) Table 11. North America Ovulation Induction Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Ovulation Induction Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Ovulation Induction Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Ovulation Induction Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Ovulation Induction Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Ovulation Induction Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Ovulation Induction Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Ovulation Induction Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Ovulation Induction Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Ovulation Induction Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Ovulation Induction Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Ovulation Induction Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Ovulation Induction Market Size Share by Application (2021-2026) Table 24. Global Ovulation Induction Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Ovulation Induction Market Size Share Forecasted by Application (2027-2032) Table 26. North America Ovulation Induction Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Ovulation Induction Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Ovulation Induction Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Ovulation Induction Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Ovulation Induction Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Ovulation Induction Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Ovulation Induction Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Ovulation Induction Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Ovulation Induction Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Ovulation Induction Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Ovulation Induction Industry Trends Table 37. Ovulation Induction Industry Drivers Table 38. Ovulation Induction Industry Opportunities and Challenges Table 39. Ovulation Induction Industry Restraints Table 40. Global Ovulation Induction Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Ovulation Induction Revenue Market Share by Company (2021-2026) Table 42. Global Ovulation Induction Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Ovulation Induction Key Company Headquarters & Area Served Table 44. Global Ovulation Induction Company, Product Type & Application Table 45. Global Ovulation Induction Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Ovulation Induction by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Company Information Table 49. Takeda Business Overview Table 50. Takeda Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Ovulation Induction Product Portfolio Table 52. Takeda Recent Development Table 53. Sanofi Company Information Table 54. Sanofi Business Overview Table 55. Sanofi Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sanofi Ovulation Induction Product Portfolio Table 57. Sanofi Recent Development Table 58. Merck & Co. Inc Company Information Table 59. Merck & Co. Inc Business Overview Table 60. Merck & Co. Inc Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Merck & Co. Inc Ovulation Induction Product Portfolio Table 62. Merck & Co. Inc Recent Development Table 63. AbbVie Company Information Table 64. AbbVie Business Overview Table 65. AbbVie Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. AbbVie Ovulation Induction Product Portfolio Table 67. AbbVie Recent Development Table 68. AstraZeneca Company Information Table 69. AstraZeneca Business Overview Table 70. AstraZeneca Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. AstraZeneca Ovulation Induction Product Portfolio Table 72. AstraZeneca Recent Development Table 73. Unichem Laboratories Company Information Table 74. Unichem Laboratories Business Overview Table 75. Unichem Laboratories Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Unichem Laboratories Ovulation Induction Product Portfolio Table 77. Unichem Laboratories Recent Development Table 78. Teva Pharmaceuticals USA, Inc Company Information Table 79. Teva Pharmaceuticals USA, Inc Business Overview Table 80. Teva Pharmaceuticals USA, Inc Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Teva Pharmaceuticals USA, Inc Ovulation Induction Product Portfolio Table 82. Teva Pharmaceuticals USA, Inc Recent Development Table 83. TerSera Therapeutics Company Information Table 84. TerSera Therapeutics Business Overview Table 85. TerSera Therapeutics Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. TerSera Therapeutics Ovulation Induction Product Portfolio Table 87. TerSera Therapeutics Recent Development Table 88. Techwell Company Information Table 89. Techwell Business Overview Table 90. Techwell Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Techwell Ovulation Induction Product Portfolio Table 92. Techwell Recent Development Table 93. Sun Pharmaceutical Company Information Table 94. Sun Pharmaceutical Business Overview Table 95. Sun Pharmaceutical Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Sun Pharmaceutical Ovulation Induction Product Portfolio Table 97. Sun Pharmaceutical Recent Development Table 98. Pharmascience Inc Company Information Table 99. Pharmascience Inc Business Overview Table 100. Pharmascience Inc Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Pharmascience Inc Ovulation Induction Product Portfolio Table 102. Pharmascience Inc Recent Development Table 103. Par pharmaceutical inc Company Information Table 104. Par pharmaceutical inc Business Overview Table 105. Par pharmaceutical inc Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Par pharmaceutical inc Ovulation Induction Product Portfolio Table 107. Par pharmaceutical inc Recent Development Table 108. Pacific Pharmaceuticals Company Information Table 109. Pacific Pharmaceuticals Business Overview Table 110. Pacific Pharmaceuticals Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Pacific Pharmaceuticals Ovulation Induction Product Portfolio Table 112. Pacific Pharmaceuticals Recent Development Table 113. LIVZON Company Information Table 114. LIVZON Business Overview Table 115. LIVZON Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. LIVZON Ovulation Induction Product Portfolio Table 117. LIVZON Recent Development Table 118. Ipsen Company Information Table 119. Ipsen Business Overview Table 120. Ipsen Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Ipsen Ovulation Induction Product Portfolio Table 122. Ipsen Recent Development Table 123. IBSA Company Information Table 124. IBSA Business Overview Table 125. IBSA Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. IBSA Ovulation Induction Product Portfolio Table 127. IBSA Recent Development Table 128. IBM Micromedex Company Information Table 129. IBM Micromedex Business Overview Table 130. IBM Micromedex Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. IBM Micromedex Ovulation Induction Product Portfolio Table 132. IBM Micromedex Recent Development Table 133. Gedeon Richter Company Information Table 134. Gedeon Richter Business Overview Table 135. Gedeon Richter Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Gedeon Richter Ovulation Induction Product Portfolio Table 137. Gedeon Richter Recent Development Table 138. Fresenius Kabi Company Information Table 139. Fresenius Kabi Business Overview Table 140. Fresenius Kabi Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Fresenius Kabi Ovulation Induction Product Portfolio Table 142. Fresenius Kabi Recent Development Table 143. Ferring Company Information Table 144. Ferring Business Overview Table 145. Ferring Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Ferring Ovulation Induction Product Portfolio Table 147. Ferring Recent Development Table 148. Endo Company Information Table 149. Endo Business Overview Table 150. Endo Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Endo Ovulation Induction Product Portfolio Table 152. Endo Recent Development Table 153. EMD Serono Inc Company Information Table 154. EMD Serono Inc Business Overview Table 155. EMD Serono Inc Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. EMD Serono Inc Ovulation Induction Product Portfolio Table 157. EMD Serono Inc Recent Development Table 158. Emcure Pharmaceuticals Ltd. Company Information Table 159. Emcure Pharmaceuticals Ltd. Business Overview Table 160. Emcure Pharmaceuticals Ltd. Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Emcure Pharmaceuticals Ltd. Ovulation Induction Product Portfolio Table 162. Emcure Pharmaceuticals Ltd. Recent Development Table 163. Cosette Pharmaceuticals, Inc Company Information Table 164. Cosette Pharmaceuticals, Inc Business Overview Table 165. Cosette Pharmaceuticals, Inc Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Cosette Pharmaceuticals, Inc Ovulation Induction Product Portfolio Table 167. Cosette Pharmaceuticals, Inc Recent Development Table 168. Bristol Myers Squibb Company Information Table 169. Bristol Myers Squibb Business Overview Table 170. Bristol Myers Squibb Ovulation Induction Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Bristol Myers Squibb Ovulation Induction Product Portfolio Table 172. Bristol Myers Squibb Recent Development Table 173. North America Ovulation Induction Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. North America Ovulation Induction Market Size by Country (2021-2026) & (US$ Million) Table 175. North America Ovulation Induction Market Share by Country (2021-2026) Table 176. North America Ovulation Induction Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. North America Ovulation Induction Market Share Forecast by Country (2027-2032) Table 178. Europe Ovulation Induction Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Europe Ovulation Induction Market Size by Country (2021-2026) & (US$ Million) Table 180. Europe Ovulation Induction Market Share by Country (2021-2026) Table 181. Europe Ovulation Induction Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Europe Ovulation Induction Market Share Forecast by Country (2027-2032) Table 183. Asia-Pacific Ovulation Induction Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Asia-Pacific Ovulation Induction Market Size by Country (2021-2026) & (US$ Million) Table 185. Asia-Pacific Ovulation Induction Market Share by Country (2021-2026) Table 186. Asia-Pacific Ovulation Induction Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Asia-Pacific Ovulation Induction Market Share Forecast by Country (2027-2032) Table 188. Latin America Ovulation Induction Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Ovulation Induction Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Ovulation Induction Market Share by Country (2021-2026) Table 191. Latin America Ovulation Induction Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Ovulation Induction Market Share Forecast by Country (2027-2032) Table 193. Middle East & Africa Ovulation Induction Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Middle East & Africa Ovulation Induction Market Size by Country (2021-2026) & (US$ Million) Table 195. Middle East & Africa Ovulation Induction Market Share by Country (2021-2026) Table 196. Middle East & Africa Ovulation Induction Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Middle East & Africa Ovulation Induction Market Share Forecast by Country (2027-2032) Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Ovulation Induction Product Image Figure 3. Global Ovulation Induction Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 5. Global Ovulation Induction Market Share by Region: 2025 VS 2032 Figure 6. Global Ovulation Induction Market Share by Region (2021-2032) Figure 7. North America Ovulation Induction Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Ovulation Induction Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Ovulation Induction Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Ovulation Induction Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Ovulation Induction Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Follicle Stimulating Hormone Image Figure 13. Global Follicle Stimulating Hormone Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Clomiphene Citrate Image Figure 15. Global Clomiphene Citrate Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Human Menopausal Gonadotropin Image Figure 17. Global Human Menopausal Gonadotropin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Human Chorionic Gonadotropin Image Figure 19. Global Human Chorionic Gonadotropin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Ovulation Induction Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Ovulation Induction Market Share by Type 2025 VS 2032 Figure 24. North America Ovulation Induction Market Size Share by Type (2021-2032) Figure 25. Europe Ovulation Induction Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Ovulation Induction Market Size Share by Type (2021-2032) Figure 27. Latin America Ovulation Induction Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Ovulation Induction Market Size Share by Type (2021-2032) Figure 29. Clinic Image Figure 30. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Hospital Image Figure 32. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Medical Institution Image Figure 34. Global Medical Institution Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Ovulation Induction Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Ovulation Induction Market Share by Application 2025 VS 2032 Figure 37. North America Ovulation Induction Market Size Share by Application (2021-2032) Figure 38. Europe Ovulation Induction Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Ovulation Induction Market Size Share by Application (2021-2032) Figure 40. Latin America Ovulation Induction Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Ovulation Induction Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Ovulation Induction Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Ovulation Induction Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Ovulation Induction Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Ovulation Induction Market Share by Country (2021-2032) Figure 47. Europe Ovulation Induction Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Ovulation Induction Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Ovulation Induction Market Share by Country (2021-2032) Figure 50. Asia-Pacific Ovulation Induction Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Ovulation Induction Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Ovulation Induction Market Share by Country (2021-2032) Figure 53. Latin America Ovulation Induction Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Ovulation Induction Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Ovulation Induction Market Share by Country (2021-2032) Figure 56. Middle East & Africa Ovulation Induction Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Ovulation Induction Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Ovulation Induction Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Follicle Stimulating Hormone
  • Clomiphene Citrate
  • Human Menopausal Gonadotropin
  • Human Chorionic Gonadotropin
  • Others
Applications
  • Clinic
  • Hospital
  • Medical Institution
Companies covered
  • Takeda
  • Sanofi
  • Merck & Co. Inc
  • AbbVie
  • AstraZeneca
  • Unichem Laboratories
  • Teva Pharmaceuticals USA, Inc
  • TerSera Therapeutics
  • Techwell
  • Sun Pharmaceutical
  • Pharmascience Inc
  • Par pharmaceutical inc
  • Pacific Pharmaceuticals
  • LIVZON
  • Ipsen
  • IBSA
  • IBM Micromedex
  • Gedeon Richter
  • Fresenius Kabi
  • Ferring
  • Endo
  • EMD Serono Inc
  • Emcure Pharmaceuticals Ltd.
  • Cosette Pharmaceuticals, Inc
  • Bristol Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Ovulation Induction Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Ovulation Induction Market Size by Region (2021-2032)
  5. 1.4.1 Global Ovulation Induction Market Size by Region (2021-2026)
  6. 1.4.2 Global Ovulation Induction Market Size by Region (2027-2032)
  7. 1.5 Key Regions Ovulation Induction Market Size (2021-2032)
  8. 1.5.1 North America Ovulation Induction Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Ovulation Induction Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Ovulation Induction Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Ovulation Induction Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Ovulation Induction Market Size Growth Rate (2021-2032)
2 Ovulation Induction Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Follicle Stimulating Hormone
  3. 2.1.2 Clomiphene Citrate
  4. 2.1.3 Human Menopausal Gonadotropin
  5. 2.1.4 Human Chorionic Gonadotropin
  6. 2.1.5 Others
  7. 2.2 Global Ovulation Induction Market Size by Type
  8. 2.2.1 Global Ovulation Induction Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Ovulation Induction Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Ovulation Induction Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Ovulation Induction Market Size by Regions
  12. 2.3.1 North America Ovulation Induction Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Ovulation Induction Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Ovulation Induction Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Ovulation Induction Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Ovulation Induction Market Size Breakdown by Type (2021-2026)
3 Ovulation Induction Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Clinic
  3. 3.1.2 Hospital
  4. 3.1.3 Medical Institution
  5. 3.2 Global Ovulation Induction Market Size by Application
  6. 3.2.1 Global Ovulation Induction Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Ovulation Induction Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Ovulation Induction Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Ovulation Induction Market Size by Regions
  10. 3.3.1 North America Ovulation Induction Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Ovulation Induction Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Ovulation Induction Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Ovulation Induction Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Ovulation Induction Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Ovulation Induction Industry Trends
  2. 4.2 Ovulation Induction Industry Drivers
  3. 4.3 Ovulation Induction Industry Opportunities and Challenges
  4. 4.4 Ovulation Induction Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Ovulation Induction Revenue (2021-2026)
  2. 5.2 Global Ovulation Induction Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Ovulation Induction Key Company Headquarters & Area Served
  4. 5.4 Global Ovulation Induction Company, Product Type & Application
  5. 5.5 Global Ovulation Induction Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Ovulation Induction Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Ovulation Induction Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Ovulation Induction Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Ovulation Induction Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Ovulation Induction Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Merck & Co. Inc
  14. 6.3.1 Merck & Co. Inc Company Information
  15. 6.3.2 Merck & Co. Inc Business Overview
  16. 6.3.3 Merck & Co. Inc Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Merck & Co. Inc Ovulation Induction Product Portfolio
  18. 6.3.5 Merck & Co. Inc Recent Developments
  19. 6.4 AbbVie
  20. 6.4.1 AbbVie Company Information
  21. 6.4.2 AbbVie Business Overview
  22. 6.4.3 AbbVie Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 AbbVie Ovulation Induction Product Portfolio
  24. 6.4.5 AbbVie Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Ovulation Induction Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Unichem Laboratories
  32. 6.6.1 Unichem Laboratories Company Information
  33. 6.6.2 Unichem Laboratories Business Overview
  34. 6.6.3 Unichem Laboratories Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Unichem Laboratories Ovulation Induction Product Portfolio
  36. 6.6.5 Unichem Laboratories Recent Developments
  37. 6.7 Teva Pharmaceuticals USA, Inc
  38. 6.7.1 Teva Pharmaceuticals USA, Inc Company Information
  39. 6.7.2 Teva Pharmaceuticals USA, Inc Business Overview
  40. 6.7.3 Teva Pharmaceuticals USA, Inc Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Teva Pharmaceuticals USA, Inc Ovulation Induction Product Portfolio
  42. 6.7.5 Teva Pharmaceuticals USA, Inc Recent Developments
  43. 6.8 TerSera Therapeutics
  44. 6.8.1 TerSera Therapeutics Company Information
  45. 6.8.2 TerSera Therapeutics Business Overview
  46. 6.8.3 TerSera Therapeutics Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 TerSera Therapeutics Ovulation Induction Product Portfolio
  48. 6.8.5 TerSera Therapeutics Recent Developments
  49. 6.9 Techwell
  50. 6.9.1 Techwell Company Information
  51. 6.9.2 Techwell Business Overview
  52. 6.9.3 Techwell Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Techwell Ovulation Induction Product Portfolio
  54. 6.9.5 Techwell Recent Developments
  55. 6.10 Sun Pharmaceutical
  56. 6.10.1 Sun Pharmaceutical Company Information
  57. 6.10.2 Sun Pharmaceutical Business Overview
  58. 6.10.3 Sun Pharmaceutical Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Sun Pharmaceutical Ovulation Induction Product Portfolio
  60. 6.10.5 Sun Pharmaceutical Recent Developments
  61. 6.11 Pharmascience Inc
  62. 6.11.1 Pharmascience Inc Company Information
  63. 6.11.2 Pharmascience Inc Business Overview
  64. 6.11.3 Pharmascience Inc Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Pharmascience Inc Ovulation Induction Product Portfolio
  66. 6.11.5 Pharmascience Inc Recent Developments
  67. 6.12 Par pharmaceutical inc
  68. 6.12.1 Par pharmaceutical inc Company Information
  69. 6.12.2 Par pharmaceutical inc Business Overview
  70. 6.12.3 Par pharmaceutical inc Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Par pharmaceutical inc Ovulation Induction Product Portfolio
  72. 6.12.5 Par pharmaceutical inc Recent Developments
  73. 6.13 Pacific Pharmaceuticals
  74. 6.13.1 Pacific Pharmaceuticals Company Information
  75. 6.13.2 Pacific Pharmaceuticals Business Overview
  76. 6.13.3 Pacific Pharmaceuticals Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Pacific Pharmaceuticals Ovulation Induction Product Portfolio
  78. 6.13.5 Pacific Pharmaceuticals Recent Developments
  79. 6.14 LIVZON
  80. 6.14.1 LIVZON Company Information
  81. 6.14.2 LIVZON Business Overview
  82. 6.14.3 LIVZON Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 LIVZON Ovulation Induction Product Portfolio
  84. 6.14.5 LIVZON Recent Developments
  85. 6.15 Ipsen
  86. 6.15.1 Ipsen Company Information
  87. 6.15.2 Ipsen Business Overview
  88. 6.15.3 Ipsen Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Ipsen Ovulation Induction Product Portfolio
  90. 6.15.5 Ipsen Recent Developments
  91. 6.16 IBSA
  92. 6.16.1 IBSA Company Information
  93. 6.16.2 IBSA Business Overview
  94. 6.16.3 IBSA Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 IBSA Ovulation Induction Product Portfolio
  96. 6.16.5 IBSA Recent Developments
  97. 6.17 IBM Micromedex
  98. 6.17.1 IBM Micromedex Company Information
  99. 6.17.2 IBM Micromedex Business Overview
  100. 6.17.3 IBM Micromedex Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 IBM Micromedex Ovulation Induction Product Portfolio
  102. 6.17.5 IBM Micromedex Recent Developments
  103. 6.18 Gedeon Richter
  104. 6.18.1 Gedeon Richter Company Information
  105. 6.18.2 Gedeon Richter Business Overview
  106. 6.18.3 Gedeon Richter Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Gedeon Richter Ovulation Induction Product Portfolio
  108. 6.18.5 Gedeon Richter Recent Developments
  109. 6.19 Fresenius Kabi
  110. 6.19.1 Fresenius Kabi Company Information
  111. 6.19.2 Fresenius Kabi Business Overview
  112. 6.19.3 Fresenius Kabi Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Fresenius Kabi Ovulation Induction Product Portfolio
  114. 6.19.5 Fresenius Kabi Recent Developments
  115. 6.20 Ferring
  116. 6.20.1 Ferring Company Information
  117. 6.20.2 Ferring Business Overview
  118. 6.20.3 Ferring Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Ferring Ovulation Induction Product Portfolio
  120. 6.20.5 Ferring Recent Developments
  121. 6.21 Endo
  122. 6.21.1 Endo Company Information
  123. 6.21.2 Endo Business Overview
  124. 6.21.3 Endo Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Endo Ovulation Induction Product Portfolio
  126. 6.21.5 Endo Recent Developments
  127. 6.22 EMD Serono Inc
  128. 6.22.1 EMD Serono Inc Company Information
  129. 6.22.2 EMD Serono Inc Business Overview
  130. 6.22.3 EMD Serono Inc Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 EMD Serono Inc Ovulation Induction Product Portfolio
  132. 6.22.5 EMD Serono Inc Recent Developments
  133. 6.23 Emcure Pharmaceuticals Ltd.
  134. 6.23.1 Emcure Pharmaceuticals Ltd. Company Information
  135. 6.23.2 Emcure Pharmaceuticals Ltd. Business Overview
  136. 6.23.3 Emcure Pharmaceuticals Ltd. Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Emcure Pharmaceuticals Ltd. Ovulation Induction Product Portfolio
  138. 6.23.5 Emcure Pharmaceuticals Ltd. Recent Developments
  139. 6.24 Cosette Pharmaceuticals, Inc
  140. 6.24.1 Cosette Pharmaceuticals, Inc Company Information
  141. 6.24.2 Cosette Pharmaceuticals, Inc Business Overview
  142. 6.24.3 Cosette Pharmaceuticals, Inc Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Cosette Pharmaceuticals, Inc Ovulation Induction Product Portfolio
  144. 6.24.5 Cosette Pharmaceuticals, Inc Recent Developments
  145. 6.25 Bristol Myers Squibb
  146. 6.25.1 Bristol Myers Squibb Company Information
  147. 6.25.2 Bristol Myers Squibb Business Overview
  148. 6.25.3 Bristol Myers Squibb Ovulation Induction Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Bristol Myers Squibb Ovulation Induction Product Portfolio
  150. 6.25.5 Bristol Myers Squibb Recent Developments
7 North America
  1. 7.1 North America Ovulation Induction Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Ovulation Induction Market Size by Country (2021-2026)
  3. 7.3 North America Ovulation Induction Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Ovulation Induction Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Ovulation Induction Market Size by Country (2021-2026)
  3. 8.3 Europe Ovulation Induction Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Ovulation Induction Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Ovulation Induction Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Ovulation Induction Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Ovulation Induction Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Ovulation Induction Market Size by Country (2021-2026)
  3. 10.3 South America Ovulation Induction Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Ovulation Induction Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Ovulation Induction Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Ovulation Induction Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst